{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["19(23)"],"submitter":["Luconi M"],"pubmed_abstract":["Developmental toxicity testing urgently requires the implementation of human-relevant new approach methodologies (NAMs) that better recapitulate the peculiar nature of human physiology during pregnancy, especially the placenta and the maternal/fetal interface, which represent a key stage for human lifelong health. Fit-for-purpose NAMs for the placental-fetal interface are desirable to improve the biological knowledge of environmental exposure at the molecular level and to reduce the high cost, time and ethical impact of animal studies. This article reviews the state of the art on the available in vitro (placental, fetal and amniotic cell-based systems) and in silico NAMs of human relevance for developmental toxicity testing purposes; in addition, we considered available Adverse Outcome Pat"],"journal":["International journal of environmental research and public health"],"pagination":["15828"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9737555"],"repository":["biostudies-literature"],"pubmed_title":["Human-Based New Approach Methodologies in Developmental Toxicity Testing: A Step Ahead from the State of the Art with a Feto-Placental Organ-on-Chip Platform."],"pmcid":["PMC9737555"],"pubmed_authors":["Sogorb MA","Benfenati E","May T","Tait S","Schmidt A","Markert UR","Wolbank S","Roncaglioni A","Luconi M","Straccia M"],"additional_accession":[]},"is_claimable":false,"name":"Human-Based New Approach Methodologies in Developmental Toxicity Testing: A Step Ahead from the State of the Art with a Feto-Placental Organ-on-Chip Platform.","description":"Developmental toxicity testing urgently requires the implementation of human-relevant new approach methodologies (NAMs) that better recapitulate the peculiar nature of human physiology during pregnancy, especially the placenta and the maternal/fetal interface, which represent a key stage for human lifelong health. Fit-for-purpose NAMs for the placental-fetal interface are desirable to improve the biological knowledge of environmental exposure at the molecular level and to reduce the high cost, time and ethical impact of animal studies. This article reviews the state of the art on the available in vitro (placental, fetal and amniotic cell-based systems) and in silico NAMs of human relevance for developmental toxicity testing purposes; in addition, we considered available Adverse Outcome Pat","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Nov","modification":"2025-04-20T03:33:59.366Z","creation":"2025-04-20T03:33:59.366Z"},"accession":"S-EPMC9737555","cross_references":{"pubmed":["36497907"],"doi":["10.3390/ijerph192315828"]}}